RTW INVESTMENTS, LP
Top Portfolio Positions
87 positions ·
$10,097,544,596 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| MDGL |
Madrigal Pharmaceuticals, Inc.
Healthcare
|
1,993,687 | $1,043,635,333 | 10.34% | |
| INSM |
INSMED Inc
Healthcare
|
4,842,880 | $791,907,737 | 7.84% | |
| PTGX |
Protagonist Therapeutics, Inc
Healthcare
|
5,059,053 | $533,224,186 | 5.28% | |
| PTCT |
Ptc Therapeutics, Inc.
Healthcare
|
7,746,415 | $527,763,253 | 5.23% | |
| ARGX |
Argenx SE
Healthcare
|
709,446 | $518,072,941 | 5.13% | |
| CGON |
CG Oncology, Inc.
Healthcare
|
6,984,808 | $472,731,805 | 4.68% | |
| CELC |
Celcuity Inc.
Healthcare
|
3,039,621 | $346,942,340 | 3.44% | |
| TNGX |
Tango Therapeutics, Inc.
Healthcare
|
13,300,620 | $278,248,970 | 2.76% | |
| ERAS |
Erasca, Inc.
Healthcare
|
16,157,175 | $261,423,091 | 2.59% | |
| NTRA |
Natera, Inc.
Healthcare
|
1,250,000 | $249,987,500 | 2.48% |
Portfolio Trend
25 quarters · across all stocks
Holdings in NTRA
Shares Held
Position Value (USD)
25 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $249,987,500 | 1,250,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $343,635,000 | 1,500,000 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $321,940,000 | 2,000,000 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $438,170,386 | 2,593,645 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $366,753,339 | 2,593,546 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $410,523,030 | 2,593,323 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $329,222,354 | 2,593,323 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $280,830,947 | 2,593,323 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $237,185,321 | 2,593,323 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $162,445,752 | 2,593,323 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $117,341,397 | 2,651,783 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $127,089,360 | 2,611,783 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $145,006,192 | 2,611,783 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $104,814,898 | 2,609,283 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $96,810,781 | 2,209,283 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $75,213,709 | 2,122,283 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $77,995,072 | 1,917,283 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $173,914,033 | 1,862,234 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $207,527,356 | 1,862,234 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $194,389,926 | 1,712,234 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $173,860,240 | 1,712,234 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $170,401,527 | 1,712,234 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $123,585,952 | 1,710,769 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $76,242,322 | 1,529,128 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $37,806,492 | 1,266,125 | Shares | Sole | 2020-05-15 | |
| No 13F history on record for this holder in this stock. | ||||||